SCHEMBL10168630

SCHEMBL10168630

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 2/20 0.54
▸ TFPI P10646 1/20 0.51
▸ GRIN2D O15399 1/20 0.49
▸ GRIN3B O60391 1/20 0.49
▸ GRIN1 Q05586 1/20 0.49
▸ GRIN2A Q12879 1/20 0.49
▸ GRIN2B Q13224 1/20 0.49
▸ GRIN2C Q14957 1/20 0.49
▸ GRIN3A Q8TCU5 1/20 0.49
▸ BECN1 Q14457 5/20 0.46
▸ PTH1R Q03431 1/20 0.46
▸ KRAS P01116 2/20 0.45
▸ NPY1R P25929 2/20 0.45
▸ NPY2R P49146 2/20 0.45
▸ NPY4R P50391 2/20 0.45
▸ NPY5R Q15761 2/20 0.45
▸ KEAP1 Q14145 1/20 0.45
▸ HRAS P01112 1/20 0.44
▸ SOS1 Q07889 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10168791 0.94 RXFP1 (0.57) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168624 0.94 RXFP1 (0.57) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168608 0.94 RXFP1 (0.57) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168584 0.94 RXFP1 (0.60) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168340 0.94 RXFP1 (0.60) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168790 0.94 RXFP1 (0.57) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168798 0.93 TFPI (0.51) RXFP1TFPINPY1RNPY2RNPY4R
SCHEMBL10168694 0.92 RXFP1 (0.59) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL16299147 0.90 RXFP1 (0.56) RXFP1TFPIGRIN2DGRIN3BGRIN1
SCHEMBL10168809 0.90 RXFP1 (0.59) RXFP1TFPIGRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028888-A1 APJ RECEPTOR COMPOUNDS ANCHOR THERAPEUTICS, INC. 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028888-A1 APJ RECEPTOR COMPOUNDS APLNR, AP1G1, AP2B1 RXFP1 827/4885TFPI 2851/4885GRIN2D 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback